Literature DB >> 8603779

Correlation between cerebral visual impairment and magnetic resonance imaging in children with neonatal encephalopathy.

G Cioni1, B Fazzi, A E Ipata, R Canapicchi, J van Hof-van Duin.   

Abstract

To identify brain lesions most often associated with cerebral visual i mpairment (CVI) after neonatal encephalopathy and to evaluate the prognostic value of MRI for visual outcome, the authors reviewed visual assessments and brain MRI of 80 infants and young children with documented perinatal hypoxic-ischaemic and/or haemorrhagic insults. MRIs were classified according to the severity of lesions at the optic radiations and at the visual cortex; visual acuity was tested with the acuity card procedure. Among the 48 children found to have a CVI, 42 had moderate to severe lesions of the optic radiations and 19 had lesions of the visual cortex. In both cases visual acuity was statically correlated with MRI grading, but the damage at the optic radiations was the better predictor. Early detection of abnormal MR findings in the visual cortex and especially, at the optic radiations may indicate which infants with neonatal encephalopthy should receive longitudinal visual assessment and specific rehabilitation and educational management.

Entities:  

Mesh:

Year:  1996        PMID: 8603779     DOI: 10.1111/j.1469-8749.1996.tb12083.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  16 in total

1.  Cryptic cerebral visual impairment in children.

Authors:  R S Lowery; D Atkinson; S R Lambert
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

2.  Correlation between visual function, neurodevelopmental outcome, and magnetic resonance imaging findings in infants with periventricular leucomalacia.

Authors:  G Cioni; B Bertuccelli; A Boldrini; R Canapicchi; B Fazzi; A Guzzetta; E Mercuri
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 3.  Vision Assessments and Interventions for Infants 0-2 Years at High Risk for Cerebral Palsy: A Systematic Review.

Authors:  Olena D Chorna; Andrea Guzzetta; Nathalie L Maitre
Journal:  Pediatr Neurol       Date:  2017-07-20       Impact factor: 3.372

4.  Cognitive assessment in epilepsy surgery of children.

Authors:  D Battaglia; D Chieffo; D Lettori; F Perrino; C Di Rocco; F Guzzetta
Journal:  Childs Nerv Syst       Date:  2006-07-12       Impact factor: 1.475

5.  Basal ganglia damage and impaired visual function in the newborn infant.

Authors:  E Mercuri; J Atkinson; O Braddick; S Anker; F Cowan; M Rutherford; J Pennock; L Dubowitz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

6.  Development of a quantitative method to measure vision in children with chronic cortical visual impairment.

Authors:  W V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2001

7.  Chronic cortical visual impairment in children: aetiology, prognosis, and associated neurological deficits.

Authors:  R Huo; S K Burden; C S Hoyt; W V Good
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

8.  Visual function in term infants with hypoxic-ischaemic insults: correlation with neurodevelopment at 2 years of age.

Authors:  E Mercuri; L Haataja; A Guzzetta; S Anker; F Cowan; M Rutherford; R Andrew; O Braddick; G Cioni; L Dubowitz; J Atkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

9.  Visual function and perinatal focal cerebral infarction.

Authors:  E Mercuri; J Atkinson; O Braddick; S Anker; L Nokes; F Cowan; M Rutherford; J Pennock; L Dubowitz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-09       Impact factor: 5.747

10.  Spectral-domain OCT changes in retina and optic nerve in children with hypoxic-ischaemic encephalopathy.

Authors:  L Grego; S Pignatto; E Busolini; N Rassu; F Samassa; R Prosperi; C Pittini; L Cattarossi; Paolo Lanzetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.